ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements with these filters
Capillary Technologies clarified that recent stock price movement is market-driven and that the company has disclosed all material information as required by SEBI regulations.
Kotak Mahindra Mutual Fund acquired 93,281 shares of Capillary Technologies, crossing the 5% ownership threshold. No transaction value was disclosed in the Reg 29(1) filing.
Mirae Asset Mutual Fund decreased its shareholding in Capillary Technologies India Ltd by selling 1,75,842 shares. This disclosure was filed under SEBI SAST regulations.
Capillary Technologies India Limited appointed seven senior management personnel including Mr. Rishi Pratim Ray as Director - Finance. The appointments across finance, legal, and regional leadership take effect from September 1, 2026.
Capillary Technologies India Limited held its 14th Annual General Meeting on August 28, 2026. The meeting covered the adoption of financial statements and the re-appointment of a director.
Capillary Technologies clarified that the promoter's recent 4% equity sale was a liquidity event for an investor, not a change in founder commitment or strategy.
Kotak Mahindra Mutual Fund acquired additional shares in Capillary Technologies India Ltd, increasing its stake to over 5.00%. The fund acquired 93,281 shares, representing a 0.1174% stake.
Promoter Capillary Technologies International Pte. Ltd. sold 3,292,428 shares (4.14% stake) in Capillary Technologies India Ltd via a block deal. The promoter's holding decreased to 44.78%.
Q1 FY27 revenue grew 43% YoY to INR 256 Cr. Management is leveraging AI-led migrations and SessionM acquisition to drive EBITDA margin expansion (17% overall, 20% organic).
Capillary Technologies acquired the CustomerGlu software platform and intellectual property from Marax AI, Inc. The acquisition integrates GenAI-powered gamification tools into Capillary's loyalty platform.
Capillary Technologies reported Q1 FY2027 revenue of ₹256.64 Crore, a 43% year-on-year increase. Profitability improved with Adjusted EBITDA rising 132% to ₹44.02 Crore.
Capillary Technologies reported Q1 FY27 revenue of ₹2,566.4 Mn (up 43% YoY) and Adjusted EBITDA of ₹440.2 Mn (up 132% YoY), despite an exceptional loss from a cyber fraud incident.
Capillary Technologies India Ltd reported revenue from operations of ₹256.6 Cr (+42.6% YoY) and a net loss of ₹9.6 Cr for Q1 FY27.
Capillary Technologies informs shareholders about the availability of the 14th AGM notice and Annual Report 2025-26 via electronic links, per SEBI regulations.
Capillary Technologies India Limited has submitted its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026, as per SEBI regulations.
Capillary Technologies India Limited filed its Integrated Annual Report for FY 2025-26, including the notice for the 14th Annual General Meeting.
Capillary Technologies India Limited has issued the notice for its 14th Annual General Meeting scheduled for August 28, 2026. The meeting will be conducted via video conferencing.
Capillary Technologies initiated a forensic audit following suspected fraudulent and unauthorized banking transactions. KPMG has been appointed to investigate the incident and recommend corrective measures.
Capillary Technologies India Limited has scheduled a board meeting for August 4, 2026, to consider and approve its standalone and consolidated financial results.
Mr. Sunil M Jain has resigned as Head - Corporate Development, designated as Senior Management Personnel. His last working day is July 31, 2026.
Capillary Technologies India Limited allotted equity shares under its ESOP/ESPS scheme. This issuance increased the total number of shares to 15,91,77,462.
Capillary Technologies India Ltd filed its quarterly shareholding pattern as of June 30, 2026. The report details equity distribution across promoter and public categories.
Capillary Technologies disclosed a EUR 3M cyber fraud at a subsidiary, impacting funds. Recovery efforts are underway; operations continue unaffected, and insurance is being assessed.
Capillary Technologies granted 7,45,537 ESOPs to employees under its 2021 plan. Options have an exercise price of INR 418 (INR 521.47 for US residents).
Capillary Technologies India Limited announced the resignation of Head – Finance, Mr. Ravi Jaswani, effective June 05, 2026. He departs to pursue new opportunities.
Capillary Technologies India Limited scheduled its 14th AGM for August 28, 2026. The record date for shareholder eligibility is fixed as August 21, 2026.
Capillary Technologies presentation focuses on its transition to an AI-native company, leveraging its 'aiRA' suite to enhance loyalty management across 415+ brands globally.
Capillary Technologies reported Q4 FY26 revenue of ₹191cr and annual revenue of ₹734cr, driven by AI-powered loyalty solutions and M&A integrations.
Capillary Technologies India Limited submitted its Monitoring Agency Report for the quarter ended March 31, 2026. The report, issued by CRISIL Ratings, tracks the utilization of ₹345.00 Crore in IPO proceeds. Most funds remain unutilized and are currently deployed in fixed deposits, while ₹18.83 Crore has been spent on issue-related expenses.
Capillary Technologies reported strong FY26 growth, closing with ₹734cr revenue. Profitability is driven by organic platform expansion and aggressive M&A of low-margin competitors upgraded to their high-margin AI stack.